|
[Related PubMed/MEDLINE]
Total Number of Papers: 330
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: MGIT |
| Long Form |
: Mycobacteria Growth Indicator Tube |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
|
CI, mPCR, MTBC, NPV, PPV |
| 2 |
2022 |
A Rare Case of Multidrug-Resistant Lupus Vulgaris with a Mixed Pattern of Resistance - A Long Journey to Diagnosis and Treatment. |
ATT, CBNAAT, MDR, TB, XDR |
| 3 |
2022 |
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid. |
AST, MTBC, Pa |
| 4 |
2022 |
Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China. |
CSF, mNGS, NPVs, TBM, ZN |
| 5 |
2022 |
Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system. |
LFA |
| 6 |
2022 |
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations. |
MDR-TB, MIC, PAS |
| 7 |
2022 |
Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. |
AUCs, BALF, mNGS, NTM-PD, ROC |
| 8 |
2022 |
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis. |
MICs, MODS |
| 9 |
2022 |
Evaluation of GeneXpert and liquid culture for detection of Mycobacterium tuberculosis in pediatric patients. |
AFB, Mtb |
| 10 |
2022 |
High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis. |
CI, eCFU, LJ, TB-MBLA, Xpert ultra |
| 11 |
2022 |
Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia. |
AFB, ATS/IDSA, NTM, PNTM, PNTM, TB |
| 12 |
2022 |
Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia. |
AFB, EQA, IQC, PT |
| 13 |
2022 |
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy. |
CRP, IQR, TB, TB-MBLA, TTP |
| 14 |
2022 |
Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes. |
CC, ECOFF, MABA, Mtb, pDST, TB, TTP |
| 15 |
2022 |
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts. |
CFU, LAM, Mtb, TB |
| 16 |
2022 |
Susceptibility pattern of Mycobacterium tuberculosis over a period of five years at Indus Hospital and Health Network, Karachi, Pakistan. |
DR |
| 17 |
2022 |
Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures. |
AST, MTBC, SPH, WGS |
| 18 |
2022 |
Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory. |
MALDI-TOF MS, NTM, RGM, SGM |
| 19 |
2022 |
Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai. |
CBNAAT, DRT, DST, Mtb, NGS, PMDT, TB, WGS, WHO |
| 20 |
2021 |
A Case of Colonic Tuberculosis Revealed by Polymerase Chain Reaction. |
LJ |
| 21 |
2021 |
Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. |
Ct, GEE, LJ, PLHIV, TTP |
| 22 |
2021 |
Comparison of different diagnostic modalities for isolation of Mycobacterium Tuberculosis among suspected tuberculous lymphadenitis patients. |
AFB, DST, LJ, MDR, Mtb, RIF |
| 23 |
2021 |
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing. |
DST, MICs, NGS |
| 24 |
2021 |
Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India. |
DR-TB, DST, FQs, MTBC, SLIDs, WHO |
| 25 |
2021 |
Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India. |
FM, LJ, LPA, MTB/RIF, NAAT, NTEP, ZN |
| 26 |
2021 |
Evaluation of the performance of a novel sputum processing ReaSLR methodology for culture of sputum samples in solid and liquid media in comparison with modified Petroff's method. |
CDC, LJ, Mtb, NALC |
| 27 |
2021 |
Improved detection of Mycobacterium tuberculosis and M. bovis in African wildlife samples using cationic peptide decontamination and mycobacterial culture supplementation. |
CFU, MTBC |
| 28 |
2021 |
On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex. |
AST, CCs, FDA, RIF, WHO |
| 29 |
2021 |
Pattern of Drug Resistance in Primary Spinal Tuberculosis: A Single-Center Study From India. |
MDR, pre-XDR, XDR |
| 30 |
2021 |
Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa. |
CI, HHCs, TB |
| 31 |
2021 |
Performance of QuantaMatrix Microfluidic Agarose Channel system integrated with mycobacteria growth indicator tube liquid culture. |
DST, LJ, QMAC |
| 32 |
2021 |
Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. |
AP, EPTB, ICT, IRL, LJ, LPA, MTBC, NTM, PTB, TB, ZN |
| 33 |
2021 |
Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013. |
aPR, CI, MDR-TB, MIC |
| 34 |
2021 |
Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. |
CF, TTP |
| 35 |
2021 |
Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis. |
ANOVA, LPG, Mtb, NRP, SRB, TB |
| 36 |
2021 |
The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures. |
TB |
| 37 |
2020 |
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial. |
CI, IQR, LJ, TB |
| 38 |
2020 |
Combination of Xpert MTB/RIF and MTBDRplus for Diagnosing Tuberculosis in a Chinese District. |
MDR-TB, RIF, TB |
| 39 |
2020 |
Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: A multicentre prospective study. |
cfDNA, TBM |
| 40 |
2020 |
Comparison of Diagnostic Yield of Tuberculosis Loop-Mediated Isothermal Amplification Assay With Cartridge-Based Nucleic Acid Amplification Test, Acid-Fast Bacilli Microscopy, and Mycobacteria Growth Indicator Tube Culture in Children With Pulmonary Tuberculosis. |
AFB, CBNAAT, CI, Mtb, TB |
| 41 |
2020 |
Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates. |
AS, CM, LPA, MTBC, NTM |
| 42 |
2020 |
Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis. |
TTP |
| 43 |
2020 |
Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens. |
RIF |
| 44 |
2020 |
Evaluation of Various Diagnostic Techniques for the Diagnosis of Pulmonary and Extra Pulmonary Tuberculosis at a Tertiary Care Center in North India. |
TB |
| 45 |
2020 |
Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India. |
MDR-TB, NRA, OFX, PCR |
| 46 |
2020 |
High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. |
PZA |
| 47 |
2020 |
Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York. |
MDR, RIF, WGS |
| 48 |
2020 |
Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria. |
AFB, LJ, MDR-TB, TB |
| 49 |
2020 |
Profile of Nontuberculous Mycobacteria in Patients Suspected of Tuberculosis and Drug-Resistant Tuberculosis. |
DR-TB, Mtb, NTM, PSC |
| 50 |
2020 |
Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study. |
MTBC, WGS |
| 51 |
2020 |
The MPB64 immunochromatography assay: an analysis of doubtful results. |
MTBC, TB, TBcId, WHO |
| 52 |
2020 |
The yield of Auramine O staining using led microscopy with bleach treated sputum samples for detection of pulmonary tuberculosis at St. Peter tuberculosis specialized hospital, Addis Ababa, Ethiopia. |
AFB, AO, LED, NPV, PPV, TB, WHO, ZN |
| 53 |
2020 |
Utility of smear microscopy and GeneXpert for the detection of Mycobacterium tuberculosis in clinical samples. |
AFB, AO, Mtb, NPV, NTM, PPV, RIF, ZN |
| 54 |
2020 |
Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study. |
AP, BMD, CCs, DST, EQA |
| 55 |
2020 |
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. |
CSF, Xpert Ultra |
| 56 |
2019 |
Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones. |
FQ, LFX, TB |
| 57 |
2019 |
Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting. |
AC, DST, Mtb, TATs |
| 58 |
2019 |
An automated smear microscopy system to diagnose tuberculosis in a high-burden setting. |
MS, TB |
| 59 |
2019 |
Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. |
BMI, RePORT, TB, TTP |
| 60 |
2019 |
Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates. |
MTBC, RIF |
| 61 |
2019 |
Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis. |
DST, LJ, MDR-TB, MODS, TB |
| 62 |
2019 |
Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda. |
OM-S |
| 63 |
2019 |
Isolation and analysis of the molecular epidemiology and zoonotic significance of Mycobacterium tuberculosis in domestic and wildlife ruminants from three states in India. |
CAS, EAI, LJ, MB, MT, MTC, OADC, PCR |
| 64 |
2019 |
Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached? |
CD, TB |
| 65 |
2019 |
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients. |
PTB, TB |
| 66 |
2019 |
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia. |
DST |
| 67 |
2019 |
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture. |
MBL, TTP |
| 68 |
2019 |
Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability. |
eCFU, MBLA, TB |
| 69 |
2019 |
Multiplex Polymerase Chain Reaction for diagnosis of gastrointestinal tuberculosis. |
BACTEC, GITB, NPV, PCR, PPV |
| 70 |
2019 |
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. |
DST, HSR-rpoB, MAS, MDR-TB |
| 71 |
2019 |
Performance of bioMerieux Lowenstein-Jensen slopes in plastic tube packaging, compared to existing phenotypic methods, for efficient recovery of the Mycobacterium tuberculosis complex. |
bMx, LJ, Mtb |
| 72 |
2019 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naive patients in Nairobi, Kenya. |
AG/CP, FQ, KAN, KEMRI, MDR-TB, NALC, RIF, TB, ZN |
| 73 |
2019 |
Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt. |
DST, MDR, RIF |
| 74 |
2019 |
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania. |
HRM, KCRI, LJ, MDR, TB |
| 75 |
2019 |
Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory. |
AST, MDR-TB, RIF |
| 76 |
2019 |
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. |
DSTs, MODS, NRA, REMA, RR |
| 77 |
2019 |
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. |
DST, MTBC |
| 78 |
2019 |
Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture. |
--- |
| 79 |
2019 |
[Evaluation of Anyplex MTB/NTM Test for The Detection of Mycobacterium tuberculosis in Clinical Specimens]. |
PCR, RT-PCR |
| 80 |
2018 |
Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation. |
CC, EMB, MYCOTB, RIF |
| 81 |
2018 |
Badgers as a potential source of bovine tuberculosis - first studies in Poland. |
bTB |
| 82 |
2018 |
Cervical tuberculous lymphadenitis: Clinical profile and diagnostic modalities. |
EPTB, MTBC, PCR |
| 83 |
2018 |
Comparison of Lowenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV. |
CI, HR, LJ, OR, TB |
| 84 |
2018 |
Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. |
WGS |
| 85 |
2018 |
Do additional colonoscopic biopsies increase the yield of Mycobacterium tuberculosis culture in suspected ileo-colonic tuberculosis? |
CI, ITB |
| 86 |
2018 |
Efficacy and role of Xpert® Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis. |
AFB, MTB/RIF |
| 87 |
2018 |
Evaluation of manual Mycobacterium growth indicator tube for isolation and susceptibility testing of Mycobacterium tuberculosis for implementation in low and medium volume laboratories. |
DST, LJ, Mtb |
| 88 |
2018 |
Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis. |
WGS |
| 89 |
2018 |
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study. |
--- |
| 90 |
2018 |
Growth characteristics of liquid cultures increase the reliability of presumptive identification of Mycobacterium tuberculosis complex. |
DST, MTBC |
| 91 |
2018 |
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. |
MIC |
| 92 |
2018 |
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. |
DST, EMB, MDR-TB, PCR, SM |
| 93 |
2018 |
OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport. |
LJ, OM-S, SDP, TB |
| 94 |
2018 |
Performance of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Specimens from Non-Cystic Fibrosis Patients. |
AFC, MALDI-TOF MS, NTM, RGM30 |
| 95 |
2018 |
rpoB Targeted Loop-Mediated Isothermal Amplification (LAMP) Assay for Consensus Detection of Mycobacteria Associated With Pulmonary Infections. |
LAMP |
| 96 |
2018 |
The Role of MGIT 960 Culture Medium in Resolving the Diagnostic Dilemma for Genital Tuberculosis Patients Presenting with Infertility. |
GTB |
| 97 |
2018 |
Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting. |
TB |
| 98 |
2017 |
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens. |
LJ |
| 99 |
2017 |
A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe. |
DST, LJ, MDR-TB, MODS, TAT |
| 100 |
2017 |
Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India. |
DST, FQ, LVX, MDR-TB, MIC, MXF, OFX, RIF |
|
A Search Service for Abbreviation / Long Form
